Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole dose comparison for marginal ulcer prevention after one anastomosis gastric bypass
IRCT20190128042520N7Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of pantoprazole in anastomotic ulcer, sponsored by Iran University of Medical Sciences. Primary endpoint: Marginal ulcer. Started Jun 2024; status: completed.
02
Drugs
pantoprazole
03
Conditions
anastomotic ulcer
Beyond the preview
Go deeper on IRCT20190128042520N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190128042520N7.